Clinical trial
Using Nevirapine to Prevent Mother-to-Child HIV Transmission During…
NCT00074412 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00074412 |
|---|---|
| Title | Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding |
| Official title | A Phase III Trial to Determine the Efficacy and Safety of an Extended Regimen of Nevirapine in Infants Born to HIV-Infected Women to Prevent Vertical HIV Transmission During Breastfeeding |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH National Institute on Drug Abuse (NIDA) National Institute of Mental Health (NIMH) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Nevirapine, Nevirapine placebo |
| Enrollment | 2,026 |
| Start date | Jan 1, 2007 |
| Primary completion | Sep 1, 2011 |
| Completion | Nov 1, 2011 |
| First posted | Dec 15, 2003 |
| Last update posted | Feb 16, 2023 |
| Countries | South Africa, Tanzania, Uganda, Zimbabwe |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: